INC Expands Oncology Team

INC Research has named Chris Smyth, Ph.D., MBA, to its oncology leadership team as senior vice president, Clinical Development. Based out of INC’s European headquarters in Winnersh, UK, Dr. Smyth will leverage his extensive oncology expertise to support the company’s oncology development and service delivery efforts in Europe and Asia Pacific.

“We’ve built a strong, global reputation for excellence in oncology by having a dedicated team with the clinical expertise to proactively manage the unique challenges associated with cancer clinical trials,” said Alistair Macdonald, general manager and executive vice president, Oncology at INC Research. “We’re delighted to have someone of Chris’ caliber on board to augment our reputation and capacity to run the highest quality cancer trials and to serve our global customers’ current and future needs.”

Dr. Smyth brings more than 20 years of research and development experience in the pharmaceutical industry, having started his career working in clinical operations roles for CROs. Prior to joining INC Research, he spent eight years at a biopharmaceutical company specializing in the development of small molecules, biologicals and DNA aptamers for the treatment of cancer. He has held senior management positions within CRO and biopharmaceutical companies in both Europe and the U.S. and has been solely focused on hematology and oncology drug development since 2003.